Filius Bart
SEC insider (Form 3/4/5 filer). CIK 0002115417. Director at ProQR Therapeutics N.V. (PRQR). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 17, 2026. Located in LEIDEN.
Companies Filius Bart has filed insider reports for
- ProQR Therapeutics N.V. (PRQR): Director
Filius Bart
CIK: 0002115417
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRQR
ProQR Therapeutics N.V.
Director